Testing effectiveness (Phase 2)UnknownNCT04759664
What this trial is testing
LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC
Who this might be right for
EGFRI Induced Acneiform Lesions
Lutris Pharma Ltd. 117